Block listing Interim Review
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline Share Option Plan - Ordinary Shares |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
3,530,802 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
2,142,9521 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
1,569,653 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
4,104,101
|
|||
|
1 This figure includes an adjustment of +142,952 unallotted securities that were allotted under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan but originally debited from the balance for this Scheme. |
||||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline Share Option Plan - ADS |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
9,349,738 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
553,924 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
8,795,814 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
Glaxo Wellcome UK Share Option Scheme |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
5,119,750 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
5,119,750 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
Glaxo Wellcome International Share Option Scheme |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
13,267,156 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
13,267,156 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
Glaxo Wellcome 1999 Share Option Plan |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
1,040,000 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1,040,000 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
163,606 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
163,606 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
275,420 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
275,420 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
100,000 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
100,000 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline Savings Related Share Option Scheme |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
2,742,626 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
2,742,626 (the GlaxoSmithKline Savings Related Share Option Scheme has now expired. The balance of 2,742,626 un-allotted shares under this Scheme has therefore lapsed) |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc Share Save Plan 2012 |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
239,107 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
2,000,000 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
603,782 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1,635,325 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan |
|||
|
Period of return: |
From: |
1 November 2016 |
To: |
30 April 2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
0 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
600,000 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
399,9291 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
200,071 |
|||
|
1 This figure includes an adjustment of +142,952 allotted securities that were allotted under this Scheme but originally debited from the balance for the block listing under the GlaxoSmithKline Share Option Plan - Ordinary Shares. |
||||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
This information is provided by RNS
Latest directors dealings
- 25 minutes ago Mattioli Woods
- 58 minutes ago Morgan Advanced Materials
- 1 hour ago Capita
- 1 hour ago Judges Scientific
- 1 hour ago Me Group International